World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio (Q38395937)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2015

Language	Label	Description	Also known as
English	World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio	scientific article published on April 2015

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatio (English)

1 reference

Europe PubMed Central

2 September 2017

0 references

0 references

suicide prevention

0 references

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Birte Yding Glenthøj

5

object named as

Birte Glenthøj

0 references

object named as

Peter Falkai

2

0 references

1

object named as

Alkomiet Hasan

1 reference

Europe PubMed Central

2 September 2017

Hans-Jürgen Möller

8

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

2 September 2017

Jeffrey Lieberman

4

object named as

Jeffrey Lieberman

1 reference

Europe PubMed Central

2 September 2017

Wagner Farid Gattaz

6

object named as

Wagner F Gattaz

1 reference

Europe PubMed Central

2 September 2017

author name string

Thomas Wobrock

3

1 reference

Europe PubMed Central

2 September 2017

Florence Thibaut

7

1 reference

Europe PubMed Central

2 September 2017

WFSBP Task Force on Treatment Guidelines for Schizophrenia

9

1 reference

Europe PubMed Central

2 September 2017

publication date

1 April 2015

1 reference

Europe PubMed Central

2 September 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

2 September 2017

16

1 reference

Europe PubMed Central

2 September 2017

3

1 reference

Europe PubMed Central

2 September 2017

142-170

1 reference

Europe PubMed Central

2 September 2017

Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Motivational interviewing among psychiatric in-patients with substance use disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antecedents and patterns of suicide behavior in first-admission psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

How to grade categories of evidence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicidality before and in the early phases of first episode psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Excess mortality of schizophrenia. A meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Psychiatric comorbidities and schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Schizophrenics kill themselves too: a review of risk factors for suicide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Smoking, nicotine and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide attempts associated with akathisia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Psychosocial approaches to dual diagnosis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Managing comorbid schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Use and safety of antipsychotic drugs during pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Bupropion for depression in schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Risks and benefits of bupropion treatment in schizophrenia: a systematic review of the current literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Clozapine and suicide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Psychotropic drug use during breastfeeding: a review of the evidence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antipsychotic therapy during early and late pregnancy. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Comorbidity of severe psychotic disorders with measures of substance use

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Integrating services for schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicidal risk during treatment with clozapine: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide and schizophrenia: a systematic review of rates and risk factors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Treatment of substance abusing patients with comorbid psychiatric disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A systematic review of instruments to measure depressive symptoms in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Pharmacological treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

How to read and understand and use systematic reviews and meta-analyses

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Cannabis use and psychosis: theme introduction.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Venlafaxine for the treatment of depressive episode during the course of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Managing psychosis in pregnancy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Clozapine and suicide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Sexuality, reproduction, and family planning in women with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Design and validation of standardized clinical and functional remission criteria in schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Treatment of dual diagnosis disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Women with schizophrenia: pregnancy outcome and infant death among their offspring.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Change in suicide rates for patients with schizophrenia in Denmark, 1981-97: nested case-control study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Absolute risk of suicide after first hospital contact in mental disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The Lifetime Risk of Suicide in Schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antidepressant Usage in Schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide risk in schizophrenia: learning from the past to change the future

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Indications for electroconvulsive treatment in schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Completed suicide in schizophrenia: evidence from a case-control study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide risk in first episode psychosis: a selective review of the current literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Gone to Pot - A Review of the Association between Cannabis and Psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Analysis of three interventions for substance abuse treatment of severely mentally ill people.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Treatment of depression in first episode of schizophrenia: results from EUFEST.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Depression during the longitudinal course of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Clinical interventions for women with schizophrenia: pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Impact of clozapine on completed suicide

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Suicide and schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Prevalence of alcohol and drug abuse in schizophrenic inpatients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Successful acamprosate treatment of alcohol dependence in schizophrenia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antipsychotic drugs and pregnant or breastfeeding women: the issues for mental health nurses

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

'Akinetic Depression' in Schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Mortality in current and former users of clozapine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antidepressants for the treatment of depression in people with schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Pharmacotherapy of schizophrenia patients with comorbid substance abuse.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Treatment of depressive symptoms in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression in schizophrenia patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1009163

21 January 2018

Identifiers

10.3109/15622975.2015.1009163

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38395937&oldid=1512618214"